- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non-small-cell Lung Cancer (NSCLC)
Total 8003 results
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedRecurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Fox Chase Cancer CenterMillennium Pharmaceuticals, Inc.TerminatedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer RecurrentUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer
-
National Cancer Institute (NCI)CompletedRecurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruitingNon-squamous Non-small-cell Lung CancerChina
-
Tianjin Medical University Cancer Institute and...RecruitingNon-squamous Non-small Cell Lung CancerChina
-
Yongchang ZhangRecruitingNon-Squamous Non Small Cell Lung CancerChina
-
SanofiActive, not recruitingNon-squamous Non-small Cell Lung CancerBelgium, Italy, Spain, Japan, United States, France, Turkey
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedNon-squamous, Non-Small Cell Lung CancerUnited Kingdom
-
Intergroupe Francophone de Cancerologie ThoraciqueCompletedNon-squamous Non-small Cell Lung CancerFrance
-
Daiichi Sankyo, Inc.ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary...TerminatedNon Squamous, Non-small-cell Lung CancerPoland, France, Germany, Italy, Spain, Canada, United States, Argentina, Belgium, Mexico, Australia, Russian Federation, Netherlands, Peru, Brazil, Austria, United Kingdom, Sweden, Czechia, Chile, Denmark, Hungary, Romania
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerUnited States, Italy, Canada, Austria, Finland, France, Greece, Korea, Republic of, Panama, Portugal, Spain, Turkey, United Kingdom, Taiwan, Brazil, Germany, Poland, Chile, Guatemala, Russian Federation, Switzerland, Thailand, Ukraine, Serb... and more
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerPortugal
-
Lingyu LuoUnknownNon-squamous Non-small Cell Lung Cancer
-
Qilu Pharmaceutical Co., Ltd.CompletedNon-squamous Non-small Cell Lung CancerChina
-
Fujian Cancer HospitalUnknownNon-squamous Non-small Cell Lung Cancer
-
Jian FangPeking University First Hospital; Peking University Third Hospital; The Second...Unknown
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerSpain
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerGermany
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerGermany
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerFrance
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerSpain, Taiwan, Japan, United States, France, Germany, Korea, Republic of, Malaysia
-
Hoffmann-La RocheTerminatedNon-Squamous Non-Small Cell Lung CancerRomania
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung CancerSpain, France, United States, United Kingdom, Latvia, Italy, Israel, Argentina, Germany
-
Mayo ClinicNational Cancer Institute (NCI)CompletedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Lung Adenocarcinoma | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Extensive Stage Small Cell Lung Carcinoma | Squamous Cell Lung Carcinoma | Recurrent Small Cell Lung CarcinomaUnited States
-
Beth Israel Medical CenterSt. Luke's-Roosevelt Hospital CenterTerminatedNonsquamous Nonsmall Cell Neoplasm of Lung | Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB/IVUnited States
-
National Cancer Center Hospital EastAstraZeneca; Japan Agency for Medical Research and Development; Japan Clinical...Not yet recruitingNon Small Cell Lung Cancer Stage III | Superior Sulcus Tumor | Non-small Cell Lung Cancer Stage IIB
-
Daiichi SankyoDaiichi Sankyo Co., Ltd.Active, not recruitingNon-Small Cell Lung Cancer Metastatic | Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor ReceptorUnited States, Spain, Korea, Republic of, France, United Kingdom, Taiwan, Australia, Japan, China, Netherlands, Italy, Germany, Austria, Belgium, Bulgaria, Singapore
-
Hellenic Cooperative Oncology GroupCompletedNon Small Cell Lung Cancer | EGF-R Positive Non-Small Cell Lung Cancer | EGFR Gene Mutation
-
Cancer Institute and Hospital, Chinese Academy...UnknownNon Small Cell Lung Cancer | Stage III Non-small-cell Lung Cancer | EGFR Mutation-Related Tumors
-
Abramson Cancer Center of the University of PennsylvaniaActive, not recruitingNon-small Cell Lung CancerUnited States
-
M.D. Anderson Cancer CenterMirati Therapeutics Inc.RecruitingAdvanced Solid Tumor | Non-small Cell Lung CancersUnited States
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingNon Small Cell Lung Cancer | Nonsquamous Nonsmall Cell Neoplasm of Lung | Non Small Cell Lung Cancer Metastatic | Sensitizing EGFR Gene MutationUnited States, Korea, Republic of, Singapore, Taiwan
-
NeoImmuneTechRoche Pharma AGActive, not recruitingCarcinoma, Non-Small-Cell Lung | Non-Small Cell Lung Cancer | Non Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Non-Small Cell Lung CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingLung Non-Squamous Non-Small Cell Carcinoma | Stage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage II Lung Non-Small Cell Cancer AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7United States, Puerto Rico
-
NovaRx CorporationCompletedLung Neoplasm | Carcinoma Non-small Cell Lung Cancer Stage IIIA | Carcinoma Non-small Cell Lung Cancer Stage IIIB | Carcinoma Non-small Cell Lung Cancer Stage IVUnited States, Hungary, United Kingdom, Netherlands, Canada, India, Poland, Serbia
-
University Health Network, TorontoPfizerRecruitingNon-squamous Non-small-cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | ROS1 Gene Rearrangement | MET Activating Mutation | MET AmplificationCanada
-
Chongqing University Cancer HospitalRecruitingNon-Small Cell Lung Cancer (NSCLC)China
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Lung Non-Small Cell Carcinoma | Stage IV Non-Small Cell Lung Cancer AJCC v7United States, Canada
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
Megan Daly, MDNational Cancer Institute (NCI); Genentech, Inc.TerminatedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI); Celgene CorporationCompletedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
BiocadUnknownNon Small Cell Lung Cancer Stage IIIB | Non-Small Cell Carcinoma of Lung, TNM Stage 4Russian Federation, Belarus
-
European Institute of OncologyUniversity of Rome Tor VergataRecruitingLung Cancer | Non-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage II | Lung Cancer DiagnosisItaly
-
Hoffmann-La RocheCompletedNon-Small Cell Lung Cancer, Lung Cancer, CancerChina
-
Henan Provincial People's HospitalChia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownStudy of Anlotinib Combined With Pemetrexed in Patients With Advanced Nonsquamous NSCLC (ALTER-L025)Non-squamous Cell Non-Small Cell Lung CancerChina
-
National Cancer Institute (NCI)TerminatedStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Stage II Non-small Cell Lung Cancer | Adenocarcinoma of the Lung | Bronchoalveolar Cell Lung Cancer | Large Cell Lung CancerUnited States
-
Novartis PharmaceuticalsActive, not recruitingALK-positive NSCLCBelgium, Spain, Italy, Australia, United States, Hong Kong, Canada, Singapore
-
Shanghai JMT-Bio Inc.Not yet recruitingSquamous Cell Non-small Cell Lung Cancer